|
1
|
Richards CH, Mohammed Z, Qayyum T, Horgan
PG and McMillan DC: The prognostic value of histological tumour
necrosis in solid organ malignant disease: a systematic review.
Future Oncol. 7:1223–1235. 2011.
|
|
2
|
Caruso R, Parisi A, Bonanno A, et al:
Histologic coagulative tumour necrosis as a prognostic indicator of
aggressiveness in renal, lung, thyroid and colorectal carcinomas: A
brief review. Oncol Lett. 3:16–18. 2012.
|
|
3
|
Swinson DE, Jones JL, Richardson D, Cox G,
Edwards JG and O’Byrne KJ: Tumour necrosis is an independent
prognostic marker in non-small cell lung cancer: correlation with
biological variables. Lung Cancer. 37:235–240. 2002.
|
|
4
|
Jimenez RE, Wallis T and Visscher DW:
Centrally necrotizing carcinomas of the breast: a distinct
histologic subtype with aggressive clinical behavior. Am J Surg
Pathol. 25:331–337. 2001.
|
|
5
|
Livasy CA, Karaca G, Nanda R, et al:
Phenotypic evaluation of the basal-like subtype of invasive breast
carcinoma. Mod Pathol. 19:264–271. 2006.
|
|
6
|
Hiltzik D, Carlson DL, Tuttle RM, Chuai S,
et al: Poorly differentiated thyroid carcinomas defined on the
basis of mitosis and necrosis: a clinicopathologic study of 58
patients. Cancer. 106:1286–1295. 2006.
|
|
7
|
Pollheimer MJ, Kornprat P, Lindtner RA, et
al: Tumour necrosis is a new promising prognostic factor in
colorectal cancer. Hum Pathol. 41:1749–1757. 2010.
|
|
8
|
Richards CH, Roxburgh CS, Anderson JH, et
al: Prognostic value of tumour necrosis and host inflammatory
responses in colorectal cancer. Br J Surg. 99:287–294. 2012.
|
|
9
|
Hiraoka N, Ino Y, Sekine S, et al: Tumour
necrosis is a postoperative prognostic marker for pancreatic cancer
patients with a high interobserver reproducibility in histological
evaluation. Br J Cancer. 103:1057–1065. 2010.
|
|
10
|
Lam JS, Shvarts O, Said JW, Pantuck AJ, et
al: Clinicopathologic and molecular correlations of necrosis in the
primary tumour of patients with renal cell carcinoma. Cancer.
103:2517–2525. 2005.
|
|
11
|
Leibovich BC, Blute ML, Cheville JC, Lohse
CM, Frank I, Kwon ED, et al: Prediction of progression after
radical nephrectomy for patients with clear cell renal cell
carcinoma: a stratification tool for prospective clinical trials.
Cancer. 97:1663–1671. 2003.
|
|
12
|
Sengupta S, Lohse CM, Leibovich BC, et al:
Histologic coagulative tumour necrosis as a prognostic indicator of
renal cell carcinoma aggressiveness. Cancer. 104:511–520. 2005.
|
|
13
|
Katz MD, Serrano MF, Grubb RL 3rd, et al:
Percent microscopic tumour necrosis and survival after curative
surgery for renal cell carcinoma. J Urol. 183:909–914. 2010.
|
|
14
|
Delahunt B, McKenney JK, Lohse CM, et al:
A novel grading system for clear cell renal cell carcinoma
incorporating tumor necrosis. Am J Surg Pathol. 37:311–322.
2013.
|
|
15
|
Pichler M, Hutterer GC, Chromecki TF, et
al: Histologic tumour necrosis is an independent prognostic
indicator for clear cell and papillary renal cell carcinoma. Am J
Clin Pathol. 137:283–289. 2012.
|
|
16
|
Pichler M, Hutterer GC, Chromecki TF,
Pummer K, Mannweiler S and Zigeuner R: Presence and extent of
histological tumour necrosis is an adverse prognostic factor in
papillary type 1 but not in papillary type 2 renal cell carcinoma.
Histopathology. 62:219–228. 2013.
|
|
17
|
Jain RK and Carmeliet PF: Vessels of death
or life. Sci Am. 285:38–45. 2001.
|
|
18
|
Weidner N: Tumour vascularity and
proliferation: clear evidence of a close relationship. J Pathol.
189:297–299. 1999.
|
|
19
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: a basic biological phenomenon with wideranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
|
|
20
|
Majno G and Joris I: Apoptosis, oncosis,
and necrosis. An overview of cell death. Am J Pathol. 146:3–15.
1995.
|
|
21
|
Kroemer G, El-Deiry WS, Golstein P, et al;
Nomenclature Committee on Cell Death. Classification of cell death:
recommendations of the Nomenclature Committee on Cell Death. Cell
Death Differ. 12(Suppl 2): 1463–1467. 2005.
|
|
22
|
Galluzzi L, Vitale I, Abrams JM, Alnemri
ES, Baehrecke EH, Blagosklonny MV, et al: Molecular definitions of
cell death subroutines: recommendations of the Nomenclature
Committee on Cell Death 2012. Cell Death Differ. 19:107–120.
2012.
|
|
23
|
Kroemer G, Galluzzi L, Vandenabeele P,
Abrams J, Alnemri ES, Baehrecke EH, et al; Nomenclature Committee
on Cell Death 2009. Classification of cell death: recommendations
of the Nomenclature Committee on Cell Death 2009. Cell Death
Differ. 16:3–11. 2009.
|
|
24
|
Vanlangenakker N, Vanden Berghe T and
Vandenabeele P: Many stimuli pull the necrotic trigger, an
overview. Cell Death Differ. 19:75–86. 2012.
|
|
25
|
Al-Nafussi AI and Hughes DE: Histological
patterns of tumours and tumour-like conditions. Histological
Diagnosis of Tumours by Pattern Analysis. Arnold; London: pp.
11–18. 1997
|
|
26
|
Hasebe T, Sasaki S, Imoto S, Mukai K,
Yokose T and Ochiai A: Prognostic significance of fibrotic focus in
invasive ductal carcinoma of the breast: a prospective
observational study. Mod Pathol. 15:502–516. 2002.
|
|
27
|
Nishimura R, Hasebe T, Tsubono Y, et al:
The fibrotic focus in advanced colorectal carcinoma: a hitherto
unrecognized histological predictor for liver metastasis. Virchows
Arch. 433:517–522. 1998.
|
|
28
|
Watanabe I, Hasebe T, Sasaki S, et al:
Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin
expression correlate with outcome. Pancreas. 26:326–333. 2003.
|
|
29
|
Jass JR: Classification of colorectal
cancer based on correlation of clinical, morphological and
molecular features. Histopathology. 50:113–130. 2007.
|
|
30
|
Caruso RA, Napoli P, Nania A, Parisi A,
Fedele F and Zuccalà V: Mitochondrion-rich differentiated
adenocarcinomas of the stomach: clinicopathological,
immunohistochemical and electron microscopy study of nine cases.
Virchows Arch. 456:499–505. 2010.
|
|
31
|
Caruso RA, Fedele F, Finocchiaro G, et al:
Microvascular changes in human gastric carcinomas with coagulative
necrosis: an ultrastructural study. Ultrastruct Pathol. 32:184–188.
2008.
|
|
32
|
Caruso RA, Fedele F, Rigoli L, et al:
Apoptotic-like tumour cells and apoptotic neutrophils in
mitochondrion-rich gastric adenocarcinomas: a comparative study
with light and electronmicroscopy between these two forms of cell
death. Rare Tumours. 5:68–71. 2013.
|
|
33
|
Dutta S, Going JJ, Crumley AB, et al: The
relationship between tumour necrosis, tumour proliferation, local
and systemic inflammation, microvessel density and survival in
patients undergoing potentially curative resection of oesophageal
adenocarcinoma. Br J Cancer. 106:702–710. 2012.
|
|
34
|
Watanabe Y, Shimizu M, Itoh T and
Nagashima K: Intraglandular necrotic debris in gastric biopsy and
surgical specimens. Ann Diagn Pathol. 5:141–147. 2001.
|
|
35
|
Caruso RA, Rigoli L, Parisi A, et al:
Neutrophil-rich gastric carcinomas: light and electron microscopic
study of 9 cases with particular reference to neutrophil apoptosis.
Ultrastruct Pathol. 37:164–170. 2013.
|
|
36
|
Flint A and Lloyd RV: Pulmonary metastases
of colonic carcinoma. Distinction from pulmonary adenocarcinoma.
Arch Pathol Lab Med. 116:39–42. 1992.
|
|
37
|
Greenson JK, Bonner JD, Ben-Yzhak O, et
al: Phenotype of microsatellite unstable colorectal carcinomas:
Well-differentiated and focally mucinous tumours and the absence of
dirty necrosis correlate with microsatellite instability. Am J Surg
Pathol. 27:563–570. 2003.
|
|
38
|
Reid MD, Basturk O, Thirabanjasak D, et
al: Tumour-infiltrating neutrophils in pancreatic neoplasia. Mod
Pathol. 24:1612–1619. 2011.
|
|
39
|
Leteurtre E, Zerimech F, Piessen G, et al:
Relationships between mucinous gastric carcinoma, MUC2 expression
and survival. World J Gastroenterol. 12:3324–3331. 2006.
|
|
40
|
Baehrecke EH: Growth control: p53, the
guardian angel of compensatory proliferation. Curr Biol.
16:R840–R842. 2006.
|
|
41
|
Castedo M, Perfettini JL, Roumier T,
Andreau K, Medema R and Kroemer G: Cell death by mitotic
catastrophe: a molecular definition. Oncogene. 23:2825–2837.
2004.
|
|
42
|
Ianzini F, Bertoldo A, Kosmacek EA,
Phillips SL and Mackey MA: Lack of p53 function promotes
radiation-induced mitotic catastrophe in mouse embryonic fibroblast
cells. Cancer Cell Int. 6:112006.
|
|
43
|
Mackey MA and Ianzini F: Enhancement of
radiation-induced mitotic catastrophe by moderate hyperthermia. Int
J Radiat Biol. 76:273–280. 2000.
|
|
44
|
Roninson IB, Broude EV and Chang BD: If
not apoptosis, then what? Treatment-induced senescence and mitotic
catastrophe in tumour cells. Drug Resist Updat. 4:303–313.
2001.
|
|
45
|
Caruso R, Fedele F, Lucianò R, et al:
Mitotic catastrophe in malignant epithelial tumours: the
pathologist’s viewpoint. Ultrastruct Pathol. 35:66–71. 2011.
|
|
46
|
Caruso RA, Fedele F, Crisafulli C, et al:
Abnormal nuclear structures (micronuclei, nuclear blebs, strings,
and pockets) in a case of anaplastic giant cell carcinoma of the
thyroid: an immunohistochemical and ultrastructural study.
Ultrastruct Pathol. 35:14–18. 2011.
|
|
47
|
Caruso RA, Rigoli L, Fedele F, et al:
Modifications of nuclear envelope in tumour cells of human gastric
carcinomas: an ultrastructural study. Anticancer Res. 30:699–702.
2010.
|
|
48
|
Caruso RA, Fedele F, Consolo P, Luigiano
C, Venuti A and Cavallari V: Abnormal nuclear structures
(micronuclei, nucleoplasmic bridges, and nuclear buds) in a
pleomorphic giant cell carcinoma of the stomach. Ultrastruct
Pathol. 32:11–15. 2008.
|
|
49
|
Morse DL, Gray H, Payne CM and Gillies RJ:
Docetaxel induces cell death through mitotic catastrophe in human
breast cancer cells. Mol Cancer Ther. 4:1495–1504. 2005.
|
|
50
|
Swanson PE, Carroll SB, Zhang XF and
Mackey MA: Spontaneous premature chromosome condensation
micronucleus formation, and non-apoptotic cell death in heated HeLa
S3 cells. Ultrastructural observations. Am J Pathol. 146:963–971.
1995.
|
|
51
|
McCluggage WG, Lyness RW, Atkinson RJ, et
al: Morphological effects of chemotherapy on ovarian carcinoma. J
Clin Pathol. 55:27–31. 2002.
|
|
52
|
Honkoop AH, Pinedo HM, De Jong JS, et al:
Effects of chemotherapy on pathologic and biologic characteristics
of locally advanced breast cancer. Am J Clin Pathol. 107:211–218.
1997.
|
|
53
|
Carder P: Typing breast cancer following
primary chemotherapy. Histopathology. 35:584–585. 1999.
|
|
54
|
Spivak JL: The anaemia of cancer: death by
a thousand cuts. Nat Rev Cancer. 5:543–555. 2005.
|
|
55
|
Caro JJ, Salas M, Ward A and Goss G:
Anemia as an independent prognostic factor for survival in patients
with cancer: a systemic, quantitative review. Cancer. 91:2214–2221.
2001.
|
|
56
|
Leek RD, Landers RJ, Harris AL and Lewis
CE: Necrosis correlates with high vascular density and focal
macrophage infiltration in invasive carcinoma of the breast. Br J
Cancer. 79:991–995. 1999.
|
|
57
|
Tollefson MK, Thompson RH, Sheinin Y, et
al: Ki-67 and coagulative tumour necrosis are independent
predictors of poor outcome for patients with clear cell renal cell
carcinoma and not surrogates for each other. Cancer. 110:783–790.
2007.
|
|
58
|
Proskuryakov SY and Gabai VL: Mechanisms
of tumour cell necrosis. Curr Pharm Des. 16:56–68. 2010.
|
